Leif Groop
501 – 510 of 682
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2008
-
Mark
Assessment of exercise capacity in women with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion.
(
- Contribution to journal › Article
-
Mark
New insights into impaired muscle glycogen synthesis.
(
- Contribution to journal › Letter
-
Mark
Differences in effects of insulin glargine or pioglitazone added to oral anti-diabetic therapy in patients with type 2 diabetes What to add-Insulin glargine or pioglitazone?
(
- Contribution to journal › Article
-
Mark
Clinical risk factors, DNA variants, and the development of type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Genes and type 2 diabetes mellitus.
(
- Contribution to journal › Article
-
Mark
Can complement factors 5 and 8 and transthyretin be used as biomarkers for MODY 1 (HNF4A-MODY) and MODY 3 (HNF1A-MODY)?
(
- Contribution to journal › Article
-
Mark
Association between LTA, TNF and AGER polymorphisms and late diabetic complications.
(
- Contribution to journal › Article
-
Mark
Immigrants from the Middle-East have a different form of Type 2 diabetes compared with Swedish patients.
(
- Contribution to journal › Article
-
Mark
Expression of the transcription factor 7-like 2 gene (TCF7L2) in human adipocytes is down regulated by insulin.
(
- Contribution to journal › Article